| Crohn Disease |
1 |
1 |
| Remission |
0 |
0.77 |
| Biologic Therapy |
0 |
0.66 |
| Steroids |
0 |
0.42 |
| Adverse Effects |
0 |
0.35 |
| Patient Safety |
0 |
0.3 |
| Inflammatory Bowel Disease |
0 |
0.24 |
| Colitis |
0 |
0.21 |
| Ulcerative Colitis |
0 |
0.17 |
| Monoclonal Antibody |
0 |
0.14 |
| Anti-Tumor Necrosis Factor (Anti-TNF) |
0 |
0.1 |
| Adherence |
0 |
0.07 |
| Board Certification |
0 |
0.07 |
| Clinical Research |
0 |
0.07 |
| Europe |
0 |
0.07 |
| Receptors |
0 |
0.07 |
| Tumor |
0 |
0.07 |
| Healthcare and Medical Technology |
0 |
0.06 |
| Osteoporosis |
0 |
0.06 |
| Psoriasis |
0 |
0.06 |